1. Signaling Pathways
  2. GPCR/G Protein
  3. Leukotriene Receptor
  4. Leukotriene Receptor Inhibitors

Leukotriene Receptor Inhibitors

LTB4

LTC4/CysLT2

LTD4/CysLT1

LTE4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Leukotriene Receptor Inhibitors, Agonists & Antagonists
Product Name LTB4 LTC4/CysLT2 LTD4/CysLT1 LTE4 Purity
MK-571 sodium    
LTD4, Ki: 0.22±0.15 nM (In guinea pig lung)
LTD4, Ki: 2.1±1.8 nM (In human lung)
LTD4, pA2: 10.5
LTE4, pA2: 10.4
99.24%
Montelukast sodium    
CysLT1
  99.84%
Zafirlukast    
LTD4
  99.89%
CP-96021    
LTD4, Ki: 34±5 nM
 
Etalocib sodium
LTB4
     
Montelukast    
CysLT1
  99.94%
Pranlukast  
LTC4, Ki: 5640 nM
LTD4, Ki: 0.99 nM
LTE4, Ki: 0.63 nM
98.18%
CP-105696
LTB4, IC50: 8.42±0.26 nM
      99.81%
Fiboflapon
LTB4, IC50: 76 nM
      99.50%
MK-571    
LTD4, Ki: 0.22 nM (In guinea pig lung)
LTD4, Ki: 2.1 nM (In human lung)
LTD4, pA2: 10.5 (on guinea pig ileum)
LTE4, pA2: 10.4 (on guinea pig ileum)
98.56%
Nedocromil  
LTC4
    98.02%
12S-HHT
BLT2
      ≥99.0%
BIIL-260 hydrochloride
LTB4, Ki: 1.7 nM
      99.90%
LY255283
LTB4, IC50: ~100 nM (LTB4 binds to guinea pig lung membranes)
      98.52%
Gemilukast  
CysLT2, IC50: 25 nM
CysLT1, IC50: 1.7 nM
  99.50%
Veliflapon
LTB4
LTC4
    99.48%
Pranlukast hemihydrate  
LTC4, Ki: 5640 nM
LTD4, Ki: 0.99 nM
LTE4, Ki: 0.63 nM
99.28%
Etalocib
LTB4
      98.74%
LY223982
LTB4, IC50: 13.2 nM
      99.67%
5-O-Demethylnobiletin  
LTC4, IC50: 0.35 μM
    99.91%
(S)-Verapamil hydrochloride  
LTC4
    98.30%
Fiboflapon sodium
LTB4, IC50: 76 nM
      99.46%
Quinotolast sodium  
LTC4
    98.38%
HAMI 3379  
CysLT2
    99.76%
Darbufelone mesylate
LTB4
      99.65%
Amelubant
LTB4, Ki: 221 nM (in vital human granulocytes)
LTB4, Ki: 230 nM (in cell membranes)
      99.11%
20-Carboxy-Leukotriene B4
BLT1
      ≥98.0%
Tipelukast    
LTD4, pA2: 6.41 (In guinea-pigs)
LTE4, pA2: 6.45 (In guinea-pigs)
99.40%
Nedocromil sodium  
LTC4
   
KP496    
LTD4
  99.79%
CAY10789    
CysLT1, IC50: 2.8 ± 0.3 μM
  99.84%
(Rac)-HAMI 3379  
CysLT2
   
AS-35  
LTC4, IC50: 8 nM (In isolated guinea pig ileum)
LTD4, IC50: 4 nM (In isolated guinea pig ileum)
LTE4, IC50: 3 nM (In isolated guinea pig ileum)
Montelukast dicyclohexylamine    
CysLT1
 
BLT2 probe 1
BLT2
     
LTB4 antagonist 1
LTB4
     
SB-209247
LTB4, Ki: 0.78 nM
     
DW-1350
LTB4
     
5-LOX-IN-6
LTB4
     
CP-195543
LTB4
     
BLT2 antagonist-1
BLT2, IC50: 224 nM
     
Triptinin B    
LTD4
 
BAY-u 9773  
LTC4
LTD4
 
Iralukast    
CysLT1, pKi: 7.8
 
LTB4 antagonist 2
LTB4, IC50: 439 nM
     
Ablukast    
LTD4
  99.36%
Quininib  
CysLT2, IC50: 52 μM
CysLT1, IC50: 1.2 μM
 
CAY10583
BLT2
     
CP-96021 hydrochloride  
LTC4, Ki: 34 nM
   
LM-1484  
LTC4
CysLT1
 
RS-601    
LTD4
 
CysLT1 receptor antagonist-1    
CysLT1, IC50: 3.9 μM
 
CP-96486    
LTD4, Ki: 20 nM
 
ONO4057
LTB4, IC50: 0.7 μM
     
LTD4 antagonist 1    
LTD4, Ki: 0.57 nM
 
LY210073
LTB4, IC50: 6.2 nM
     
CI-949  
LTC4, IC50: 0.5 μM
LTD4, IC50: 0.5 μM
 
YM158 free base    
LTD4, pA2: 8.87
 
Bunaprolast
LTB4
     
LTB4-IN-1
LTB4, IC50: 70 nM